Vector VestAdvertisement
Home > Boards > US Listed > Biotechs > Arena Pharmaceuticals, Inc. (ARNA)

Your numbers and knowledge mean absolute squat to

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
gixxer11 Member Profile
 
Followed By 48
Posts 5,935
Boards Moderated 1
Alias Born 11/27/11
160x600 placeholder
Amended Statement of Ownership (sc 13g/a) "Edgar (US Regulatory)" - 1/29/2015 2:21:18 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 1/23/2015 4:52:01 PM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) "Edgar (US Regulatory)" - 1/23/2015 4:48:33 PM
Arena Pharmaceuticals Announces Agreement to Sell Common Stock "PR Newswire (US)" - 1/21/2015 8:45:00 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 1/20/2015 5:16:05 PM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) "Edgar (US Regulatory)" - 1/20/2015 4:17:35 PM
Arena Pharmaceuticals Announces Public Offering of Common Stock "PR Newswire (US)" - 1/20/2015 4:04:00 PM
Automatic Shelf Registration Statement of Securities of Well-known Seasoned Issuers (s-3asr) "Edgar (US Regulatory)" - 1/20/2015 4:03:35 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 1/20/2015 9:01:16 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 1/12/2015 4:21:38 PM
Arena Pharmaceuticals Initiates Phase 2 Clinical Trial Evaluating Ralinepag for Pulmonary Arterial Hypertension "PR Newswire (US)" - 1/12/2015 8:00:00 AM
Arena Pharmaceuticals Reports on Eisai's New Marketing Initiatives for BELVIQ® (lorcaserin HCl) CIV "PR Newswire (US)" - 1/9/2015 8:00:00 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 1/9/2015 7:32:38 AM
Arena Pharmaceuticals Reports Positive Results from Phase 1b Clinical Trial Evaluating APD334 for the Treatment of Autoimmune... "PR Newswire (US)" - 1/7/2015 8:00:00 AM
Arena Pharmaceuticals to Present at the 33rd Annual J.P. Morgan Healthcare Conference "PR Newswire (US)" - 1/6/2015 8:00:00 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 12/5/2014 5:26:42 PM
Arena Pharmaceuticals Issued Composition of Matter Patent by United States Patent and Trademark Office for Ralinepag and Rela... "PR Newswire (US)" - 11/25/2014 8:00:00 AM
Arena Pharmaceuticals to Present at Piper Jaffray 26th Annual Healthcare Conference "PR Newswire (US)" - 11/24/2014 8:00:00 AM
Arena Pharmaceuticals to Present at Stifel 2014 Healthcare Conference "PR Newswire (US)" - 11/13/2014 8:00:00 AM
Quarterly Report (10-q) "Edgar (US Regulatory)" - 11/6/2014 4:57:53 PM
Lorcaserin HCl Data to be Presented at the Annual Meeting of the American Association for the Study of Liver Diseases "PR Newswire (US)" - 11/6/2014 8:00:00 AM
Arena Pharmaceuticals to Present at Credit Suisse 2014 Healthcare Conference "PR Newswire (US)" - 11/5/2014 8:00:00 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 11/3/2014 7:31:36 AM
Arena Pharmaceuticals Provides Corporate Update and Reports Third Quarter 2014 Financial Results "PR Newswire (US)" - 11/3/2014 6:45:00 AM
Eisai and Arena Pharmaceuticals Report Results of an Investigational Phase 2 Trial of Lorcaserin HCl as an Aid for Smoking Ce... "PR Newswire (US)" - 11/3/2014 6:30:00 AM
Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist